Journals in Hematology

Atherosclerosis

ISSN: 0021-9150
5 Year impact factor: 5.3
Impact factor: 4.9

Cardiovascular disease (CVD) causes one third of all deaths worldwide and is a major threat to global health. Atherosclerosis aims to provide a comprehensive platform for researchers, clinicians and healthcare professionals to share the latest findings and advances in the field of atherosclerosis. Atherosclerosis covers a wide range of topics, including:Pathophysiology and Mechanisms: We explore the intricate cellular and molecular processes involved in atherogenesis, from the initial formation of fatty streaks to the development of complex plaques. We also welcome studies on cardiac biology and disease.Risk Factors: We consider manuscripts that examine both traditional and emerging risk factors for atherosclerosis, such as dyslipidaemia, hypertension, diabetes mellitus, thrombosis and genetic predisposition.Prevention of CVD: Since prevention will become a major focus in the future (see e.g. the European Cardiovascular Health Plan), an important focus will be on preventive strategies, including lifestyle modifications and pharmacological interventions.Diagnostics Techniques: We features articles on cutting-edge diagnostic techniques, ranging from invasive procedures such as selective coronary arteriography to non-invasive techniques such as blood biomarkers.Treatment Approaches: Atherosclerosis covers the latest developments in the treatment of atherosclerosis, including lipid-lowering therapies, anti-inflammatory treatments and novel targeted approaches aimed at modifying disease progression and improving clinical outcomes.Translational Research: We bridges the gap between basic science and clinical practice by highlighting translational studies that bring laboratory findings closer to practical applications in patient care.By fostering collaboration and knowledge exchange between researchers and clinicians, Atherosclerosis aims to accelerate progress in the understanding, prevention and treatment of atherosclerosis, ultimately improving the lives of the millions of people affected by this pervasive disease.

Subscriptions

Atherosclerosis Plus

ISSN: 1567-5688
5 Year impact factor: 1.4
Impact factor: 1.4

Previously published as Atherosclerosis Supplements .Atherosclerosis Plus is supported by the European Atherosclerosis Society.Atherosclerosis Plus publishes both original research and review papers that address the key aspects of atherosclerosis, including its pathogenesis and genetic basis, its risk factors (e.g. dyslipidemia and lipid related disorders, hypertension, obesity, diabetes), and the impact of lifestyle modifications (e.g., smoking, diet, physical activity) and nutritional and pharmacological interventions aimed at the primary and secondary prevention of cardiovascular diseases and related conditions. Types of papers that can be submitted for consideration by the Editorial Board include Original Research Papers, Brief Communications, Case Reports, and Review Articles. Finally, the journal periodically publishes special theme issues devoted to areas of current interest.

Subscriptions

Best Practice & Research Clinical Haematology

ISSN: 1521-6926
5 Year impact factor: 2.3
Impact factor: 2.2

Best Practice & Research Clinical Haematology provides a comprehensive review of current clinical practice and thinking within the specialty of haematology.All chapters are commissioned and written by an international team of practicing clinicians with the Guest Editors for each issue drawn from a pool of renowned experts and opinion leaders.All chapters take the form of practical, evidence-based reviews that seek to address key clinical issues of diagnosis, treatment and patient management.Each issue follows a problem-orientated approach that focuses on the key questions to be addressed, clearly defining what is known and not known. Management will be described in practical terms so that it can be applied to the individual patient.Boxed and bulleted Learning Objectives and Practice Points are features within each chapter and will highlight the core and essential knowledge that will help the physician to provide the best care to their patients.

Subscriptions

Biochimica et Biophysica Acta: Proteins and Proteomics

ISSN: 1570-9639
5 Year impact factor: 2.8
Impact factor: 2.5

BBA Proteins and Proteomics covers protein structure conformation and dynamics; protein folding; protein-ligand interactions; enzyme mechanisms, models and kinetics; protein physical properties and spectroscopy; and proteomics and bioinformatics analyses of protein structure, protein function, or protein regulation.The journal no longer considers manuscripts dealing with binding of compounds such as drugs or drug analogues to circulatory proteins such as serum albumin. These studies are better accommodated in journals dealing with drug design and development.Manuscripts must advance our insights into the molecular and mechanistic properties of proteins. Computational studies must generally be validated or complemented by experimental studies. Studies only consisting of computational work will not be considered unless they provide new theoretical insight that allows us to better understand or reinterpret surprising or unexpected experimental data.Comparative proteomics studies are generally not considered for review unless they provide specific insights into the structural and/or functional properties of individual proteins. Proteomics studies must also address properties of individual proteins and should as far as possible be validated by direct investigations of relevant identified proteins.Concise and comprehensive reviews of recent developments are considered for publication. However, authors are strongly advised to consult one of the Executive Editors before starting a review.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Blood Cells, Molecules and Diseases

ISSN: 1079-9796
5 Year impact factor: 2.2
Impact factor: 2.1

BCMD is interested in contributions in basic, translational and clinical research focusing on the biology of blood cells and the pathophysiology of blood disorders, with a specific interest in non-malignant conditions.We will consider studies on hematological malignancies when secondary to inherited or acquired bone marrow failure or disorders of the immune system.Research Areas include:Erythropoiesis, Erythrocyte Biology, Hemoglobin and its disordersMyelopoiesis, myeloid cells and disorders of the myeloid lineage (incl. myeloproliferative disorders)Megakaryopoiesis and platelet disordersHemostasis & Thrombosis and disorders of coagulationTransfusion medicine and the study of therapeutic blood products (including novel biotechnologies related to transfusion products)Bone marrow failure (severe aplastic anemia, myelodysplasia, etc.)Immunodeficiency and dysregulation of the immune systemAuto-immune disorders relating to blood

Subscriptions

Blood Reviews

ISSN: 0268-960X
5 Year impact factor: 7.7
Impact factor: 6.9

This respected international journal, Blood Reviews, is a vital information resource, bringing together appraisals of clinical practice, and research from recognized experts. Specially commissioned peer reviewed articles from leading researchers and practitioners guarantee truly global coverage of all the sub-specialties of hematology.Blood Reviews publishes review articles covering the spectrum of clinical and laboratory haematological practice and research. Although most reviews are invited, the Editors welcome suggestions from potential authors. They should first write a brief outline of an intended review along with their publication record on topic and send this to Dr Drew Provan ([email protected]) or to Dr Hillard Lazarus ([email protected]). All articles are subject to peer review. Author queries can also be sent to the Blood Reviews editorial office [email protected]

Subscriptions

Cancer Epidemiology

ISSN: 0361-090X
5 Year impact factor: 2.7
Impact factor: 2.4

Cancer determinants, prevention, prognosis and outcomesCancer Epidemiology publishes original research, prioritizing studies that contribute new information about cancer causes, prevention and control. As such, the journal's scope covers all aspects of cancer epidemiology including studies of:• Risk factors for cancer initiation, development, and prognosis • Early detection, prevention, and screening • Survivorship • Descriptive patterns and trends • MethodologyCancer Epidemiology welcomes original articles, reviews (systematic and critical), meta-analyses, invited editorials and commentaries, as well as letters to the editor commenting on research previously published in the journal.Cancer Epidemiology (Cancer Epidemiol.) is indexed and abstracted in: MEDLINE/PubMed, Current Contents/Clinical Medicine, the Science Citation Index Expanded, and Thomson Reuters Journal Citation Reports (Science Edition).

Subscriptions

Cancer Epidemiology

ISSN: 1877-7821
5 Year impact factor: 2.7
Impact factor: 2.4

Subscriptions

Cancer Letters

ISSN: 0304-3835
5 Year impact factor: 8.3
Impact factor: 9.1

An international journal providing a forum for original and pertinent contributions in cancer researchCancer Letters is an international journal that considers full-length articles and Mini Reviews in the broad area of basic and translational oncology. Additionally, Special Issues highlight topical areas in cancer research. Basic areas of interest to a broad readership of Cancer Letters include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal places emphasis on experimental therapeutics, particularly targeted therapies for personalized cancer medicine, including metronomic chemotherapy.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: https://service.elsevier.com.

Subscriptions

Cancer Treatment Reviews

ISSN: 0305-7372
5 Year impact factor: 10.9
Impact factor: 9.6

Cancer Treatment Reviews is an international journal that provides state of the art, authoritative review articles to the clinician and researcher to keep them abreast of modern concepts and the latest developments in cancer treatment research.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support CenterJournal of Cancer Treatment Reviews' Inclusion and Diversity PledgeThis journal pledges to maintain diversity on the editorial team. This sits within Elsevier's broader ongoing inclusion & diversity efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation. We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.

Subscriptions

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Journals in Hematology

Atherosclerosis

Atherosclerosis Plus

Best Practice & Research Clinical Haematology

Biochimica et Biophysica Acta: Proteins and Proteomics

Blood Cells, Molecules and Diseases

Blood Reviews

Cancer Epidemiology

Cancer Epidemiology

Cancer Letters

Cancer Treatment Reviews